Showing results (221-230 of 283) with videos related to
Sort By:
Pageof 29
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis CYuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, et al.Hepatology International|April 26, 2023
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failureSerami Murakami, Michio Imamura, Takuro Uchida, et al.Liver Cancer|August 21, 2023
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular CarcinomaYuwa Ando, Tomokazu Kawaoka, Masanari Kosaka, et al.Journal of Gastroenterology and Hepatology|January 3, 2020
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy casesKana Daijo, Takashi Nakahara, Yuki Inagaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2014
Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinomaHatsue Fujino, Tomoki Kimura, Hiroshi Aikata, et al.BMC Cancer|June 6, 2018
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trialMasahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, et al.Journal of Medical Virology|June 29, 2017
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patientsHiromi Kan, Michio Imamura, Yoshiiku Kawakami, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 6, 2013
[A case of clonorchiasis complicated with the expansion of liver cyst]Yoko Kominami, Hiroshi Aikata, Ken Hiramatsu, et al.Clinical and Translational Gastroenterology|July 18, 2020
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular CarcinomaMasami Yamauchi, Atsushi Ono, Akira Ishikawa, et al.Journal of Gastroenterology and Hepatology|November 20, 2015
Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort studyYuko Nagaoki, Hiroshi Aikata, Norihito Nakano, et al.Pageof 29